The Food and Drug Administration approved 35 new medications in fiscal year 2011, the most in a decade, with the exception of 2009.
Many of the drugs are groundbreaking – including medications to treat Hepatitis C, prostate cancer, lupus and drug-resistant skin infections.
Colorado Sen. Michael Bennet has advocated changes to the FDA’s approval process since he took office in 2009, and applauded the agency for its efforts to modernize the focus and process.
“But we can and must do more to insure the FDA is a driver of global innovation in the 21st century,” he said. “I look forward to further collaborations that will encourage faster approvals of safe and effective lifesaving therapies. The progress will be crucial in states like Colorado with entrepreneurial horsepower, a skilled workforce and top-tier research institutions.”
In August, Bennet wrote a letter to FDA commission Margaret Hamburg, pushing for reforming the FDA’s regulations that cover the drug therapy approval process.